The global market for stroke diagnostic and therapeutic products was estimated to be worth USD 32.69 billion in 2021 and is expected to reach USD 65.45 billion by 2030, growing at a projected CAGR of 8% from 2022 to2030. Expanding geriatric populations and rising Neuroscience disease rates will be the main factors driving the stroke management market. Over 70 years old made up 56% of aortic valve stenosis patients in Europe. Additionally, a number of government agencies have started awareness campaigns to lower the frequency of strokes and brain disorders among the elderly population. For instance, the Patient Protection and Affordable Care Act (ACA) in the United States provides health coverage to more than 20 million people, including senior citizens.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
